American National Insurance’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

American National Insurance’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,500	Closed	-$241K	–	356
2021 Q2	$241K	Hold	3,500	–	–	0.01%	345
2021 Q1	$270K	Hold	3,500	–	–	0.01%	332
2020 Q4	$346K	Hold	3,500	–	–	0.01%	311
2020 Q3	$497K	Hold	3,500	–	–	0.02%	272
2020 Q2	$691K	Hold	3,500	–	–	0.04%	244
2020 Q1	$686K	Hold	3,500	–	–	0.04%	218
2019 Q4	$724K	Hold	3,500	–	–	0.04%	239
2019 Q3	$534K	Hold	3,500	–	–	0.03%	258
2019 Q2	$451K	Hold	3,500	–	–	0.02%	266
2019 Q1	$412K	Hold	3,500	–	–	0.02%	273
2018 Q4	$321K	Hold	3,500	–	–	0.02%	279
2018 Q3	$394K	Buy	+3,500	New	+$370K	0.02%	282

Other funds holding LKFT

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

American National Insurance's LKFT Position: Q3 2021 in Review

American National Insurance sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2021, closing a stake of 3,500 shares — an estimated $241K sold.

American National Insurance first reported a position in LKFT in Q3 2018 and held it in 12 quarters. The position peaked at $724K in Q4 2019. 81 funds tracked by Wall St. Rank hold LKFT as of Q3 2021.

American National Insurance reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2021 after selling out during the quarter.
American National Insurance sold 3,500 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2021, an estimated $241K.
American National Insurance first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2018 and held it in 12 quarters.
American National Insurance's Lakefront Biotherapeutics American Depositary Shares position peaked at $724K in Q4 2019.
81 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2021.

Based on American National Insurance's 13F filing for Q3 2021, filed 15 Nov 2021.